A clinical trial to study the effects of two drugs, nalbuphine and fentanyl in patients undergoing caesarean section.
Phase 4
Recruiting
- Conditions
- Health Condition 1: null- Term Pregnant females undergoing caesarean section
- Registration Number
- CTRI/2017/08/009399
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Term Pregnant females with ASA Grade I,II
Exclusion Criteria
1.Patientâ??s refusal
2.Any spine abnormality
3.Altered coagulation profile
4.Allergy to local anaesthetic
5.Recent myocardial infarction
6.Significant aortic stenosis
Patients with neurological disorders
Cardiac or respiratory system failure
Any major hepatic or renal problem
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sensory blockade <br/ ><br>Motor blockade <br/ ><br>VAS <br/ ><br>Timepoint: Sensory blockade: continuouslyâ?? till onset then every 10 minutesâ?? till regression <br/ ><br>Motor blockade at 5,10,15 minutes then every 10minutes till regression <br/ ><br>3.VAS: every 15 minutes in the first hour then hourly for 4 hours then at 12hours and 24 hours after spinal blockade <br/ ><br>
- Secondary Outcome Measures
Name Time Method Sedation scale <br/ ><br>Complications <br/ ><br>Vitals <br/ ><br>Timepoint: Intraoperative